![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Fryer A. The XY girl. Paediatric and adolescent gynaecology., A Garden. Arnold, London 1998; 201–209
- Kalidas M, Hilsenbeck S, Brown P. Defining the role of raloxifene for the prevention of breast cancer. Journal of the National Cancer Institute 2004; 96: 1731–1733
- Leow M K, Loh K C. 46XY female, a case report. Annals of Academic Medicine Singapore 2001; 30: 71–75
- Loh F H. Use of hormone replacement therapy in the asymptomatic postmenopausal woman: what is the current evidence?. Annals of Academic Medicine Singapore 2003; 32: 605–610
- Mizunuma H, Soda M, Okano H, Kagami I, Miyamoto S, Ohsawa M, et al. Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome. Human Reproduction 1998; 13: 2816–2818
- Obianwu C W, Palter S P, Bruno A A. Bilateral laparoscopic gonadectomy in a patient with complete androgen insensitivity a case report. Journal of Reproductive Medicine 1996; 41: 270–272
- Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002; 288: 321–333
- Soule S G, Conway G, Prelevic G M, Prentice M, Ginsburg J, Jacobs H S. Osteopenia as a feature of the androgen insensitivity syndrome. Clinical Endocrinology (Oxford) 1995; 43: 671–675